G W Rankin Jr
Overview
Explore the profile of G W Rankin Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schultz E, Rankin Jr G, Blanc M, Raden B, Tsai C, Rose T
J Virol
. 2000 Apr;
74(10):4919-28.
PMID: 10775636
We have cloned and characterized the entire DNA polymerase gene and flanking regions from Kaposi's sarcoma-associated herpesvirus (KSHV) and two closely related macaque homologs of KSHV, retroperitoneal fibromatosis-associated herpesvirus-Macaca nemestrina...
2.
Diamond C, Huang M, Kedes D, Speck C, Rankin Jr G, Ganem D, et al.
J Infect Dis
. 1997 Sep;
176(3):775-7.
PMID: 9291331
The prevalence of human herpesvirus 8 (HHV-8)/Kaposi's sarcoma (KS)-associated herpesvirus was investigated in the semen of 99 human immunodeficiency virus (HIV)-infected men (median CD4 cell count, 357/mm3) by use of...
3.
Rose T, Strand K, Schultz E, Schaefer G, Rankin Jr G, Thouless M, et al.
J Virol
. 1997 May;
71(5):4138-44.
PMID: 9094697
Simian retroperitoneal fibromatosis (RF) is a vascular fibroproliferative neoplasm which has many morphological and histological similarities to human Kaposi's sarcoma (KS). Like epidemic KS in AIDS patients, RF is highly...
4.
Wang X, Terasaki P, Rankin Jr G, Chia D, Zhong H, Hardy S
Hum Immunol
. 1993 Aug;
37(4):264-70.
PMID: 8300411
We present a microtest for cell-mediated immunity, based on the use of the Tarasaki tray and calcein AM vital dye. The number of target cells needed has been reduced to...
5.
Rankin Jr G, Wang X, Terasaki P
Clin Transpl
. 1990 Jan;
:417-24.
PMID: 2103164
1. Greater than 50% PRA-sensitized first kidney graft recipients show significantly lower graft survival rates than nonsensitized (0-10% PRA) and moderately sensitized (11-50% PRA) recipients. Most of the effect of...